TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

ourResearchBanner

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

A Prospective, Multicenter Study to Assess the Safety and Efficacy of Translingual Neurostimulation Plus Physical Therapy for the Treatment of a Chronic Balance Deficit Due to Mild‐to‐Moderate Traumatic Brain Injury
Neuromodulation: Technology at the Neural Interface I April 29, 2020

Translingual neurostimulation for the treatment of chronic symptoms due to mild-to-moderate traumatic brain injury
Archives of Rehabilitation Research and Clinical Translation | Sept 27, 2019

Human translingual neurostimulation alters resting brain activity in high-density EEG
Journal of NeuroEngineering and Rehabilitation I May 27, 2019

Emerging Noninvasive Neurostimulation Technologies: CN-NINM and SYMPATOCORECTION
Journal of Behavioral and Brain Science | Mar 01, 2014

Closing an Open-Loop Control System: Vestibular Substitution Through the Tongue
Journal of Integrative Neuroscience | Dec 01, 2003

Should any additional information regarding PoNSTM be required, please submit a completed medical information request form.
Medical Information Request Form